One developer of a weight loss medication, clinical-stage biotech Structure Therapeutics ( GPCR 0.16%), was a victim of a ...

Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...

Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Under Armour Inc. Cl C 1.89% $2.96B Under Armour Inc. Cl A 1.68% $2.96B ...

The stock has risen in six out of the last 10 trading sessions. –Net Profit Down 53% At ₹64.2 Cr Vs ₹136 Cr (YoY) –Revenue Down 2.8% At ₹1,016 Cr Vs ₹1,045 Cr (YoY) –EBITDA Down 62% At ₹83 Cr Vs ...